Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE

Marketwatch2021-12-08

Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

riserr
2021-12-09
riserr
Up up all the way

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1196789631?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-08 07:29","share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","id":"1196789631","market":"us","top_or_hot":-1,"title":"Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE","media":"Marketwatch","content":"<div>\n<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of...</p>\n\n<a href=\"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing\">网页链接</a>\n\n</div>\n","source":"market_watch","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDare Bioscience Shares Rally After FDA OKs Xaciato >DARE\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of...</p>\n\n<a href=\"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DARE","symbol_name":"Dare Bioscience","start_time":0,"source_url":"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing","article_id":"1196789631","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196789631","pubTimestamp":1638919795,"sourceInfo":{"source_id":"market_watch","name":"华尔街大事件"},"weMediaInfo":null,"summary":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and ","collect":0,"end_time":0,"defaultTopTitle":"marketwatch.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"DARE":"Dare Bioscience"},"translate_title":"美国食品和药物管理局批准Xaciato>Dare后，Dare生物科学股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DARE":0.9},"content_text":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.\nThe approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.\nDare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.\nDare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":602119706,"gmtCreate":1638980146783,"gmtModify":1638980146783,"author":{"id":"4087297988376160","authorId":"4087297988376160","name":"riserr","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":9,"crmLevelSwitch":0},"htmlText":"Up up all the way","listText":"Up up all the way","text":"Up up all the way","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602119706","repostId":1196789631,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":54,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196789631"}